Biomerica (BMRA) vs Co-Diagnostics (CODX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biomerica is the larger company by market cap ($8.7 million vs $7.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BMRA | CODX |
|---|---|---|
| Share price | $1.89 | $1.09 |
| Market cap | $8.69M | $7.61M |
| 1-day change | -0.53% | -2.68% |
| YTD return | -24.21% | — |
| 1-year return | -32.75% | — |
| 5-year return | -95.69% | — |
| Forward P/E | 4.85 | — |
| EPS (TTM) | $-1.30 | $-26.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.21 | $46.50 |
| 52-week low | $1.45 | $0.906 |
| Distance from 52-week high | -41.12% | -97.66% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +266.97% |
| Average volume | 70.88K | 326.53K |
| Shares outstanding | 4.60M | 6.98M |
| Employees | 50 | 115 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Biomerica
BMRA stock →Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical conditions, as well as detect and measure the presence and levels of specific bacteria, hormones, antibodies, antigens, and other substances that may exist in the human body at extremely low concentrations through clinical laboratories and in point-of-care settings, including physicians' offices and over-the-counter channels.
Healthcare · Medical Devices · 50 employees
About Co-Diagnostics
CODX stock →Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Healthcare · Medical Devices · 115 employees
BMRA vs CODX FAQ
Which is bigger, Biomerica or Co-Diagnostics?
Biomerica (BMRA) is larger, with a market capitalization of $8.69M compared with $7.61M for Co-Diagnostics (CODX).
Are Biomerica and Co-Diagnostics in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.